A protein chimera self-assembling unit for drug delivery.

Area of Science:

• Biotechnology
• Nanotechnology
• Materials Science

Background:

• Selective drug delivery focuses on optimizing carriers over active compounds.
• Virus-like particles (VLPs) are bioinspired nanodevices capable of transporting diverse molecules like drugs and small interfering RNAs.

Purpose of the Study:

• To engineer and evaluate a novel VLP-based drug delivery system.
• To assess the potential of a Rotavirus A VP6 protein fused with a Small Ubiquitin Modifier domain as a drug carrier.

Main Methods:

• Constructing a fusion protein of Rotavirus A VP6 and Small Ubiquitin Modifier.
• Analyzing the self-assembly properties into nanoparticles and nanotubes.
• Evaluating the potential for drug encapsulation and delivery.
• Assessing the in vitro toxicity of the empty particles.

Main Results:

• The novel fusion protein successfully self-assembles into nanoparticles and nanotubes.
• The resulting particles demonstrate potential as drug carriers without requiring specific targeting epitopes.
• High expression and purification yields were achieved.
• The empty particles exhibited low toxicity.

Conclusions:

• The engineered Rotavirus A VP6-Small Ubiquitin Modifier fusion protein is a promising candidate for drug delivery applications.
• The bioinspired nanocarrier offers a versatile platform for transporting various bioactive molecules.
• Further studies are warranted to explore its efficacy in selective drug delivery.